Skip to content
Off-topic for aiqbench

Off-topic for aiqbench

This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.

Orbis Medicines and Novo Nordisk strike up-to-$1.4bn deal for oral cardiometabolic macrocycles

Dealroom.co1 min read

Orbis Medicines and Novo Nordisk strike up-to-$1.4bn deal for oral cardiometabolic macrocycles  Dealroom

Read the full article at Dealroom.co

Related coverage